Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -202,611 | -789,608 | -566,261 | -360,228 | -164,446 |
| Depreciation Amortization | 4,880 | 17,434 | 12,378 | 7,831 | 3,783 |
| Accounts payable and accrued liabilities | -9,519 | 23,600 | 23,280 | 6,652 | 10,590 |
| Other Working Capital | -44,708 | 46,117 | 8,469 | -35,318 | -29,165 |
| Other Operating Activity | 45,837 | 138,073 | 116,726 | 89,036 | 25,084 |
| Operating Cash Flow | $-206,121 | $-564,384 | $-405,408 | $-292,027 | $-154,154 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 235,254 | 584,059 | 387,416 | 233,438 | -17,592 |
| PPE Investments | -10,676 | -71,028 | -58,638 | -37,925 | -19,321 |
| Purchase Sale Intangibles | N/A | -5,224 | -4,224 | N/A | N/A |
| Other Investing Activity | 0 | -5,224 | -4,224 | 0 | 0 |
| Investing Cash Flow | $224,578 | $507,807 | $324,554 | $195,513 | $-36,913 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 963 | 21,187 | 19,182 | 15,004 | 10,223 |
| Financing Cash Flow | $963 | $21,187 | $19,182 | $15,004 | $10,223 |
| Beginning Cash Position | 381,709 | 417,099 | 417,099 | 417,099 | 417,099 |
| End Cash Position | 401,129 | 381,709 | 355,427 | 335,589 | 236,255 |
| Net Cash Flow | $19,420 | $-35,390 | $-61,672 | $-81,510 | $-180,844 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206,121 | -564,384 | -405,408 | -292,027 | -154,154 |
| Capital Expenditure | -10,676 | -71,028 | -58,638 | -37,925 | -19,321 |
| Free Cash Flow | -216,797 | -635,412 | -464,046 | -329,952 | -173,475 |